[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100174962":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":20,"responsibleParty":36,"collaborators":7,"id":38,"slug":7,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":43,"eligibilityCriteria":44,"healthyVolunteers":39,"sex":45,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":7,"studyType":51,"phases":7,"briefSummary":52,"conditions":53,"keywords":7,"overallStatus":23,"whyStopped":7,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},{"fullName":5,"class":6},"Helse Stavanger HF","OTHER_GOV",null,[9],{"name":10,"affiliation":5,"role":11},"Tore Grimstad, PhD","PRINCIPAL_INVESTIGATOR",[13,17],{"name":14,"role":15,"phone":7,"phoneExt":7,"email":16},"tore grimstad","CONTACT","tore.bjorn.grimstad@sus.no",{"name":18,"role":15,"phone":7,"phoneExt":7,"email":19},"lars aabakken","larsaa@medisin.uio.no",[21],{"facility":22,"status":23,"city":24,"state":7,"zip":7,"country":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"SUS","RECRUITING","Stavanger","Norway",{"type":27,"coordinates":28},"Point",[29,30],5.73332,58.97005,{"lat":30,"lon":29},[33],{"name":34,"role":15,"phone":35,"phoneExt":7,"email":7},"Tore B Grimstad, MD PhD","+47909 21 650",{"type":37,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100174962",false,"NCT01551563","Stavanger University Hospital Inflammatory Bowel Disease Trial","Management of Inflammatory Bowel Disease in the Stavanger Area - a Prospective Evaluation of Standardized Treatment Regimens on Disease Outcome With Focus on Mucosal Healing and Associations to Fatigue","SUSI","Inclusion Criteria:\n\n* newly diagnosed IBD\n\nExclusion Criteria:\n\n* previous IBD with specific treatment within 10 year\n* inability to consent\n* inability to adhere to treatment protocol","ALL","16 Years","80 Years",{"count":49,"type":50},700,"ESTIMATED","OBSERVATIONAL","The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined.\n\nCytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.",[54],"IBD","2025-05-13",{"date":57,"type":58},"2025-05-16","ACTUAL",{"date":60,"type":7},"2012-04",{"date":62,"type":50},"2030-12",{"name":5,"class":6},1]